Tirzepatide 15mg (4-Pack)
Multi-Vial Bundle — Best Value for Sustained Research
Four 15mg tirzepatide vials bundled for maximum value. Provides a 4-month supply at 15mg weekly maintenance dosing — the most cost-effective format for sustained dual GLP-1/GIP research.
Starting From
$569.99
Sold By
Apollo Peptide Sciences
Suggested Protocol
For researchers at confirmed 15mg weekly maintenance dose. Reconstitute one vial at a time with 1.5ml bacteriostatic water (10mg/ml) or 3ml (5mg/ml). SubQ injection once weekly. Store unopened vials at room temperature or refrigerated; refrigerate reconstituted vials immediately and use within 28 days.
22.5%
Body Wt. Loss
4 × 15 mg
Total Supply
~4 months
Duration
Planning for 4 Months of Continuous Tirzepatide Research — Done Right
The Tirzepatide 15mg 4-Pack delivers four standard 15mg vials as a single bundled purchase — the optimal format for researchers who have completed dose escalation and are committed to sustained maintenance-phase protocols. At 15mg weekly dosing (the peak dose from the SURMOUNT-1 trial documenting 22.5% average body weight reduction), this 4-pack provides a full 4 weeks of uninterrupted supply per vial, translating to approximately 4 months of research continuity from a single order.
The bundle economics are straightforward: four vials purchased together cost meaningfully less per milligram than four individual 15mg purchases, reducing the per-dose cost at the most effective maintenance tier. For serious tirzepatide researchers who have established tolerability and are executing long-term protocols, the 4-pack eliminates the reordering friction that interrupts protocol continuity.
Tirzepatide's dual GLP-1/GIP receptor mechanism — the compound behind Mounjaro and Zepbound — produces its most significant metabolic and body composition effects through sustained, uninterrupted dosing. Each vial reconstituted with bacteriostatic water provides a precise working concentration for weekly SubQ injections, maintaining the consistent hormonal signaling environment required for compounding metabolic benefit over time.
Why 4 Months Matters
Tirzepatide's Benefits Compound Over Multi-Month Protocols in Ways Early Results Don't Show
The first month of tirzepatide produces early fat loss as caloric intake decreases significantly. Months two and three are where the metabolic improvements deepen: insulin sensitivity continues improving, visceral fat reduction (which reduces ectopic fat deposition in organs) becomes measurable, and cardiovascular risk markers trend meaningfully. Month four and beyond show body composition settling into a new equilibrium — lean mass increasingly preserved as the body adapts to the new metabolic signaling environment. The 4-pack isn't about having backup supply; it's about having the supply continuity that allows these deeper, time-dependent benefits to fully express.
Protocol Continuity
Why Gaps in Tirzepatide Dosing Cost More Than Just a Week's Progress
Tirzepatide maintains its effects through consistent weekly plasma levels. The compound's 5-day half-life means plasma concentration drops substantially if a weekly injection is missed — but the more important issue is the hormonal signaling environment. Consistent GLP-1 and GIP receptor engagement maintains the metabolic state that drives ongoing fat loss. A gap doesn't just pause results; it partially resets the hormonal suppression of appetite that the protocol has been building. Mid-protocol reorder gaps, where you're waiting days for a new vial to arrive, are the type of disruption the 4-pack eliminates entirely.
Bundle Economics
When Bulk Purchasing Reflects the Seriousness of the Protocol, Not Just the Savings
The per-vial cost reduction in the 4-pack is meaningful — but the more important signal is what the purchase reflects: a commitment to a multi-month protocol rather than an exploratory single-vial approach. Researchers who buy a 4-pack have done the escalation, confirmed tolerability, and decided to pursue the sustained outcomes that tirzepatide's clinical data describes. The economics reinforce this commitment — having 4 months of supply on hand removes the friction points that cause protocol abandonment. Consistency is the variable that determines whether the SURMOUNT-1 outcomes apply to you.
Key Benefits
4 vials of 15mg tirzepatide — approximately 4 months of supply at maintenance dosing
Lower cost per milligram vs. four individual 15mg purchases
Eliminates reordering gaps that interrupt sustained protocol continuity
Supports full maintenance-phase research at the SURMOUNT-1 peak efficacy dose
Each vial individually sealed for storage integrity across the multi-month supply
Dual GLP-1/GIP mechanism delivers 22.5% average body weight reduction in clinical data
Single order manages the full supply horizon for a sustained research program
Compatible with bacteriostatic water for precise reconstitution at any working concentration
Full Protocol
For researchers at confirmed 15mg weekly maintenance dose. Reconstitute one vial at a time with 1.5ml bacteriostatic water (10mg/ml) or 3ml (5mg/ml). SubQ injection once weekly. Store unopened vials at room temperature or refrigerated; refrigerate reconstituted vials immediately and use within 28 days.
Best Stacked With
More in Weight Management
View All
Semaglutide
The compound behind Ozempic/Wegovy. GLP-1 receptor agonist producing significant appetite suppression, fat loss, and metabolic improvement with once-weekly dosing.
